Brand

Pacira Pharmaceuticals, Inc. Recalls

4 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Pacira Pharmaceuticals, Inc..

4Total Recalls
0Critical
85,519Units Affected
Jun 12, 2024Most Recent
All Recalls

Every Pacira Pharmaceuticals, Inc. Recall

Sorted by most recent. Click any recall for full details.

4 recalls
High RiskFDA
Pacira Pharmaceuticals Inc
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceutic...
Injectable Drugs·40,517 affected·Jun 12, 2024
High RiskFDA
Pacira Pharmaceuticals Inc
Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: P...
Injectable Drugs·43,768 affected·May 7, 2024
High RiskFDA
Pacira Pharmaceuticals, Inc.
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira...
Injectable Drugs·910 affected·Nov 21, 2019
High RiskFDA
Pacira Pharmaceuticals, Inc.
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltr...
Injectable Drugs·324 affected·Dec 17, 2012